Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Valproic Acid

Drug Monitoring

Depakote levelValproateVPA

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures the amount of valproic acid in your blood. Valproic acid is a medication used to treat seizure disorders, stabilize mood in bipolar disorder, and prevent migraines. Because the medicine’s effect and safety are closely tied to how much is in your bloodstream, checking the level helps your care team tailor your dose.

Your sample is usually drawn at a consistent time in your dosing schedule, often just before the next dose, so results can be compared reliably over time. Levels can vary with dose, timing, liver function, age, and interactions with other medicines.

Why it matters

Keeping your level in a goal range helps balance effectiveness and side effects. If the level is too low, seizures or mood symptoms may not be well controlled. If it is too high, you may be more likely to experience unwanted effects such as sleepiness, tremor, stomach upset, or more serious problems affecting the liver, pancreas, or platelets.

Your clinician may order this test when starting valproic acid, after changing the dose, when adding or removing other medicines, during pregnancy, if you have liver or kidney issues, or if you have symptoms that suggest underdosing or toxicity. Regular monitoring supports safe, individualized treatment.

Understanding your results

Your clinician will interpret the result together with how you are feeling, seizure control or mood stability, side effects, and other labs such as liver enzymes and platelets. A result below the desired range can suggest that the dose may be insufficient, doses were missed, the timing of the blood draw captured a non trough level, or another medicine is lowering your level. A result above the desired range can indicate increased risk of side effects or a drug interaction raising your level.

Do not change your dose on your own. If your level is not where it should be, your care team may adjust the dose, review timing and adherence, check for interactions, or repeat the test at a standardized time. The plan will be tailored to your condition and treatment goals.

Reference ranges

350700 umol/L
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Valproic Acid

  • Timing of the blood draw

    Levels are most useful when drawn at a trough, just before the next scheduled dose. Drawing too soon after a dose or at varying times can misrepresent your steady level.

  • Drug interactions

    Other medicines can raise or lower valproic acid levels or change the amount that is protein bound. Examples include enzyme inducers, certain antibiotics, salicylates, and other antiepileptic drugs.

  • Liver function

    Valproic acid is processed by the liver. Liver disease or heavy alcohol use can change how the drug is cleared and may increase the risk of side effects at a given level.

  • Protein binding and albumin

    Valproic acid binds to blood proteins. Low albumin or kidney disease can increase the unbound fraction, so the total level may not reflect the active amount.

  • Formulation and adherence

    Immediate release and extended release products have different absorption profiles. Missed doses, vomiting, or switching formulations can shift measured levels.

  • Pregnancy and age

    During pregnancy and in some children, the body clears valproic acid faster, which can lower levels. Older adults may clear it more slowly, increasing sensitivity.

  • Laboratory method and sample type

    Assay methods and whether serum or plasma was used can influence reported values. Consistent sampling and the same lab improve comparability.

2026

References

  1. McGill University Health Centre. (2014, September 26). Valproic Acid (Task CD 317806). Laboratory reference ranges.
  2. Patsalos, P. N., Spencer, E. P., & Berry, D. J. (2018). Therapeutic drug monitoring of antiepileptic drugs in epilepsy: A 2018 update. Therapeutic Drug Monitoring, 40(5), 526–548.
  3. National Institute for Health and Care Excellence. (2022). Epilepsies in children, young people and adults: diagnosis and management (NG217).